Tirzepatide 15mg is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research into type 2 diabetes treatment. It demonstrates superior efficacy in glucose control and weight reduction compared to other agonists like dulaglutide.
With a molecular formula of C225H348N48O68 and a molecular weight of 4813, tirzepatide 15mg features a PEG-modified lysine side chain that enhances water solubility. Its primary function is as a GIP and GLP-1 receptor dual agonist, making it a valuable compound for metabolic disorder studies.
Clinical trials, such as SURMOUNT-1, have shown that tirzepatide 15mg can lead to significant weight loss, averaging 20.9% over 72 weeks in participants. This makes it a promising candidate for obesity and overweight-related health condition research.
This product is supplied as a white powder with high purity and is packaged for research use only. It is not intended for personal consumption. Proper storage in a cold, dry, and dark environment is recommended to maintain stability.